Skip to Content
Merck

S1827

Sodium deoxycholate

Synonym(s):

3α,12α-Dihydroxy-5β-cholanic acid sodium salt, 7-Deoxycholic acid sodium salt, Desoxycholic acid sodium salt

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

100 G

¥49,200

1 KG

¥280,000

10 KG

¥1,954,000

¥49,200

Check Cart for Availability
Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):
C24H39NaO4
CAS Number:
302-95-4
Molecular Weight:
414.55
EC Number:
206-132-7
UNSPSC Code:
12161900
NACRES:
NA.21
Beilstein/REAXYS Number:
3581950
MDL number:
MFCD00064139

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

FHHPUSMSKHSNKW-SMOYURAASA-M

InChI

1S/C24H40O4.Na/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3;/h14-21,25-26H,4-13H2,1-3H3,(H,27,28);/q;+1/p-1/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-;/m1./s1

SMILES string

[Na+].[H][C@]12CC[C@@]3([H])[C@]4([H])CC[C@H]([C@H](C)CCC([O-])=O)[C@@]4(C)[C@@H](O)C[C@]3([H])[C@@]1(C)CC[C@@H](O)C2

biological source

animal

assay

≥98% (HPLC)

form

powder

mol wt

micellar avg mol wt 1200-5000

aggregation number

3-12

CMC

2-6 mM (20-25°C)

HLB

16

suitability

suitable for manufacturing use

Quality Level

400

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
30970SRE0046D6750
Sodium deoxycholate

SAFC

S1827

Sodium deoxycholate

Sodium deoxycholate BioXtra, ≥98.0% (dry matter, NT)

Sigma-Aldrich

30970

Sodium deoxycholate

Sodium deoxycholate Suitable for manufacturing of diagnostic kits and reagents

Sigma-Aldrich

SRE0046

Sodium deoxycholate

Sodium deoxycholate ≥97% (titration)

Sigma-Aldrich

D6750

Sodium deoxycholate

form

powder

form

powder

form

-

form

powder

biological source

animal

biological source

ox bile

biological source

-

biological source

-

assay

≥98% (HPLC)

assay

≥98.0% (dry matter, NT)

assay

≥98% (HPLC)

assay

≥97% (titration)

suitability

suitable for manufacturing use

suitability

-

suitability

-

suitability

-

mol wt

micellar avg mol wt 1200-5000

mol wt

micellar avg mol wt 1200-5000

mol wt

micellar avg mol wt 1200-5000

mol wt

micellar avg mol wt 1200-5000

aggregation number

3-12

aggregation number

3-12

aggregation number

3-12

aggregation number

3-12

General description

Our SAFC® portfolio of high-quality raw materials for use in biopharmaceutical processing withstands strict quality control procedures plus the documentation and expertise to help our customers meet requirements as defined by the M-Clarity Program.

M-Clarity Program

Our comprehensive portfolio of upstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Trust us to deliver supply chain transparency and reliable sourcing around the globe, streamlining your product qualification with best-in-class regulatory support and service.

Legal Information

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H302

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000500233
0000500234
0000500234
0000500233
0000487041

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

L L Liu et al.
Oncogene, 33(24), 3140-3150 (2013-07-16)
Prostate tumors develop resistance to androgen deprivation therapy (ADT) by multiple mechanisms, one of which is to express constitutively active androgen receptor (AR) splice variants lacking the ligand-binding domain. AR splice variant 7 (AR-V7, also termed AR3) is the most
Ayako Suzuki et al.
Nucleic acids research, 42(22), 13557-13572 (2014-11-08)
Here we conducted an integrative multi-omics analysis to understand how cancers harbor various types of aberrations at the genomic, epigenomic and transcriptional levels. In order to elucidate biological relevance of the aberrations and their mutual relations, we performed whole-genome sequencing
Dov B Ballak et al.
Nature communications, 5, 4711-4711 (2014-09-04)
Cytokines of the IL-1 family are important modulators of obesity-induced inflammation and the development of systemic insulin resistance. Here we show that IL-1 family member IL-37, recently characterized as an anti-inflammatory cytokine, ameliorates obesity-induced inflammation and insulin resistance. Mice transgenic
Jamie A Greig et al.
PLoS pathogens, 11(1), e1004630-e1004630 (2015-01-27)
The opportunistic human fungal pathogen, Candida albicans, undergoes morphological and transcriptional adaptation in the switch from commensalism to pathogenicity. Although previous gene-knockout studies have identified many factors involved in this transformation, it remains unclear how these factors are regulated to
Jelke J Fros et al.
The Journal of general virology, 96(Pt 3), 580-589 (2014-11-15)
The unfolded protein response (UPR) is a cellular defence mechanism against high concentrations of misfolded protein in the endoplasmic reticulum (ER). In the presence of misfolded proteins, ER-transmembrane proteins PERK and IRE1α become activated. PERK phosphorylates eIF2α leading to a
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service